The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 22: 3190 - 3195

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.22.012

Clinical Research

Relationship between macrolide⁃resistant mycoplasma pneumoniae infection and refractory Mycoplasma pneumoniae pneumonia in children

  • Qianqian CHEN ,
  • Qiuyu LIN ,
  • Xiangyun ZHANG ,
  • Dufei. ZHANG
Expand
  • Department of Pediatrics，Hainan Women and Children′s Medical Center，Haikou 570000，Hainan，China

Received date: 2024-08-08

  Online published: 2024-11-25

Fold

Abstract

Objective To elucidate the clinical significance in facilitating timely diagnosis and treatment of RMPP in children by investigating the association between infection caused by macrolide?resistant Mycoplasma pneumoniae （MRMP） and refractory Mycoplasma pneumoniae pneumonia （RMPP） in pediatric patients. Methods The clinical data of 714 hospitalized children with refractory Mycoplasma pneumoniae pneumonia （RMPP） were retrospectively analyzed. Bronchoscopy and bronchoalveolar lavage fluid （BALF） were performed on each subject， and the BALFs were collected to detect mutation sites in the V region of 23S rRNA for Mycoplasma pneumoniae DNA. Based on the gene detection results， children with RMPP were categorized into a macrolide?resistant group and a control group （non?macrolide?resistant group）. Results A total of 714 children diagnosed with refractory Mycoplasma pneumoniae pneumonia （RMPP） were enrolled in this study， including 509 cases in the macrolide?resistant group and 205 cases in the control group. Among them， there were 369 males （54.7%） and 345 females （45.3%）. The macrolide?resistant group exhibited higher average age， fever duration， and hospitalization days compared to the control group. Furthermore， elevated levels of white blood cell count （WBC）， neutrophil percentage （NE%）， high?sensitivity C?reactive protein （hs?CRP）， lactate dehydrogenase （LDH）， and interleukin?6 （IL?6） were observed in the macrolide?resistant group when compared to the control group （P < 0.05 or P < 0.000 1）. Compared to the control group， children with macrolide?resistant Mycoplasma pneumoniae pneumonia （RMPP） exhibited higher incidences of lung consolidation， pleural effusion， necrotic pneumonic lesions， severe MPP （SMPP）/fulminant MPP （FMPP）， flocculent and viscous tracheal secretions， severe mucosal lesions （erosion， ulceration or necrosis）， bronchial inflammatory stenosis， endo?bronchial plastic phlegm plugs and extra?pulmonary complications （P < 0.05 or P < 0.0001）. Conclusions MRMP infection can contribute to the development of RMPP， potentially exacerbating respiratory conditions in affected children. Timely bronchoscopy and collection of BALF samples for accurate evaluation of respiratory tract lesions and detection of MRMP infection have significant implications for guiding precise clinical diagnosis and treatment.

Key words： mycoplasma pneumoniae; macrolides resistant; gene mutation; refractory mycoplosma pneumoniae pneumonia; bronchoalveolar lavage fluid; bronchoscopy

Cite this article

Qianqian CHEN , Qiuyu LIN , Xiangyun ZHANG , Dufei. ZHANG . Relationship between macrolide⁃resistant mycoplasma pneumoniae infection and refractory Mycoplasma pneumoniae pneumonia in children[J]. The Journal of Practical Medicine, 2024 , 40(22) : 3190 -3195 . DOI: 10.3969/j.issn.1006-5725.2024.22.012

References

1 SONG Z， JIA G， LUO G， et al. Global research trends of Mycoplasma pneumoniae pneumonia in children： A bibliometric analysis［J］. Front Pediatr， 2023， 11： 1306234. doi:10.3389/fped.2023.1306234
2 鲍汝英， 徐国成. 儿童难治性肺炎支原体肺炎的发病机制及治疗进展［J］. 齐齐哈尔医学院学报， 2022， 43（13）： 1274-1278.
3 吴琰， 魏会平， 曹欣 等. 儿童下呼吸道肺炎支原体感染流行特点分析［J/CD］. 新发传染病电子杂志， 2021， 6（4）： 336-338.
4 ZHAN X W， DENG L P， WANG Z Y， et al. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia［J］. Ital J Pediatr， 2022， 48（1）： 190. doi:10.1186/s13052-022-01376-6
5 陈丹， 张娜丽， 张婷 等. 难治性肺炎支原体肺炎患儿支气管肺泡灌洗液中肺炎支原体耐药基因检测分析［J］. 中国当代儿科杂志， 2021， 23（7）： 707-712.
6 刘金荣， 刘立雍， 赵顺英， 等. 咽拭子与支气管肺泡灌洗液荧光定量PCR检测儿童肺炎支原体感染分析［J］. 疾病监测， 2019， 34（5）： 389-393.
7 国家卫生健康委员会人才交流服务中心儿科呼吸内镜诊疗技术专家组， 中国医师协会儿科医师分会内镜专业委员会， 中国医师协会内镜医师分会儿科呼吸内镜专业委员会， 等. 中国儿科可弯曲支气管镜术指南（2018年版）［J］. 中华实用儿科临床杂志， 2018， 33（13）： 983-989.
8 赵顺英， 钱素云， 陈志敏， 等. 儿童肺炎支原体肺炎诊疗指南（2023年版）［J］. 传染病信息， 2023， 36（4）： 291-297.
9 LENG M， YANG J， ZHOU J. The molecular characteristics， diagnosis， and treatment of macrolide-resistant Mycoplasma pneumoniae in children［J］. Front Pediatr， 2023， 11： 1115009. doi:10.3389/fped.2023.1115009
10 EDELSTEIN I A， IVANOVA O V， ROMASHOV O I， et al. Course of Lower Respiratory Tract Infection in Young People Treated at the Military Hospital of Smolensk Garrison with Detected Mycoplasma pneumoniae Carrying a Macrolide-Resistant Mutation in 23S rRNA Gene［J］. Pathogens， 2023， 12（1）： 103. doi:10.3390/pathogens12010103
11 JIN H L， ZHAN L， MEI S F， et al. Serum Cytokines and FeNO in School-Aged Children with Mycoplasma pneumoniae Pneumonia［J］. Med Sci Monit， 2020， 26： e923449. doi:10.12659/msm.923449
12 XIN D， MI Z， HAN X， et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China［J］. Antimicrob Agents Chemother， 2009， 53（5）： 2158-2159. doi:10.1128/aac.01563-08
13 YUAN C， MIN F M， LING Y J， et al. Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children［J］. Comb Chem High Throughput Screen， 2018， 21（10）： 749-754. doi:10.2174/1386207322666190111112946
14 LI L， MA J， GUO P， et al. Molecular beacon based real-time PCR p1 gene genotyping， macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children［J］. BMC Infect Dis， 2022， 22（1）： 724. doi:10.1186/s12879-022-07715-6
15 GUO P， MEI S， WANG Y， et al. Molecular typing of Mycoplasma pneumoniae and its correlation with macrolide resistance in children in Henan of China［J］. Indian J Med Microbiol， 2023， 46： 100435. doi:10.1016/j.ijmmb.2023.100435
16 管峥，霍洁，袁晶，等. 血清乳酸脱氢酶联合白细胞介素18对儿童难治性肺炎支原体肺炎的预测作用［J］. 实用医学杂志， 2020， 36（20）：2848-2851.
17 韩茜， 蒋凯旋， 王燕侠， 等. 儿童难治性支原体肺炎危险因素的系统评价［J］. 中国循证医学杂志， 2021， 21（10）： 1168-1173.
18 宁阳. 小儿难治性肺炎支原体肺炎的临床特点及影响因素分析［J］. 当代医学， 2021， 27（24）： 170-171.
19 尤士军，梁雪，王春莲，等. 人参五味子汤加减对肺炎支原体感染致大叶性肺炎（肺脾气虚证）患儿的疗效及炎症指标的影响［J］. 实用医学杂志， 2023， 39（24）： 3281-3285.
20 张雅静， 孟晨. 儿童难治性肺炎患儿肺炎支原体大环内酯类耐药基因突变分析［J］. 中国实用儿科杂志， 2023， 38（5）： 376-380.
21 李慧敏，宁晶晶，李志梅，等. 纤维支气管镜肺泡灌洗治疗肺炎患儿的临床分析［J］. 中国社区医师， 2022，38（31）：41-43.
22 吴卫照， 刘东成. 支气管镜肺泡灌洗治疗幼儿重症肺炎支原体肺炎的疗效观察及肺功能的变化特点［J］. 实用医学杂志， 2019， 35（1）： 132-135.
23 蔡惠东，范旻皞，徐惠良. 纤维支气管镜治疗儿童难治性肺炎支原体肺炎的效果分析［J］. 系统医学， 2023， 8（14）： 152-154，158.
24 ZHANG H， YANG J， ZHAO W， et al. Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children： A practical nomogram prediction model［J］. Eur J Pediatr， 2023， 182（3）： 1239-1249. doi:10.1007/s00431-022-04761-9
25 WANG L， XIE Q， XU S， et al. The role of flexible bronchoscopy in children with Mycoplasma pneumoniae pneumonia［J］. Pediatr Res， 2023， 93（1）： 198-206. doi:10.1038/s41390-021-01874-z
26 马晓林，丁臻博， 黄永坤. 儿童肺炎支原体对大环内酯类抗生素耐药现状及机制研究进展［J］. 国际药学研究杂志， 2020， 47（10）： 804-808.
Options
Outlines

/

〈 〉